mesalamine has been researched along with curcumin in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 15 (75.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
| Andoh, A; Arai, H; Fujiyama, Y; Hanai, H; Hiraishi, H; Hirayama, K; Iida, T; Iwaoka, Y; Kanke, K; Koide, Y; Maruyama, Y; Mitsuyama, K; Nagata, T; Sata, M; Takeuchi, K; Tsujikawa, T; Uchijima, M; Watanabe, F; Yamada, M; Yoshii, S | 1 |
| Moss, AC | 1 |
| Burpee, T; Christie, D; Cohen, M; Suskind, DL; Wahbeh, G; Weber, W | 1 |
| Ahuja, V; Kumar, A; Kumar, S; Moss, AC; Sankar, MJ | 1 |
| Ahuja, V; Choudhury, BN; Deb, R; Dhingra, R; Garg, SK; Kedia, S; Makharia, G; Pratap Mouli, V; Rai, T; Rohatgi, S; Sharma, PK; Singla, V; Tiwari, V; Verma, P | 1 |
| Avidan, B; Ben-Horin, S; Cheong, PK; Ching, JY; Eliakim, R; Gamus, D; Har-Noy, O; Kaimakliotis, I; Kopylov, U; Lahat, A; Lang, A; Ng, SC; Salomon, N; Wu, JC | 1 |
| Gamus, D; Lang, A; Salomon, N | 1 |
| Bernstein, CN | 1 |
| Holt, PR | 1 |
| Adler, J; Singer, AAM | 1 |
| Ben-Horin, S; Lang, A; Salomon, N | 1 |
| Bai, X; Duan, H; Gao, C; Liu, M; Lü, S; Qin, H; Wei, Y; Wu, X | 1 |
| Cheng, SM; Huang, MF; Huang, XY; Liu, DY; Lu, AP; Wang, X; Xu, R; Yue, HY; Zhao, HM; Zou, Y | 1 |
| Han, Z; Kaplan, DL; Li, G; Liu, L; Wang, X; Xie, X; Zheng, Z; Zhi, M | 1 |
| Agah, S; Kashani, AHF; Mahdiabadi, MA; Masoodi, M; Mokhtare, M; Rezadoost, AM; Sabzikarian, M; Sahebkar, A; Talebi, A | 1 |
| Anwar, H; Iqbal, U; Quadri, AA | 1 |
| Banerjee, R; Girish, G; Goren, I; Kathi, P; Pal, P; Penmetsa, A; Reddy, DN | 1 |
| Awasthi, A; Babu, MR; Chaitanya, MVNL; Chellappan, DK; Corrie, L; Dua, K; Dureja, H; Gulati, M; Gupta, G; Jha, NK; Kala, D; Kaur, J; Khursheed, R; Kumar, A; Kumar, B; Kumar, D; Muhammed, RA; Pandey, NK; Porwal, O; Prasher, P; Singh, SK; Vishwas, S | 1 |
| Banaszkiewicz, A; Dembiński, Ł; Pituch-Zdanowska, A | 1 |
3 review(s) available for mesalamine and curcumin
| Article | Year |
|---|---|
Curcumin for maintenance of remission in ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Curcumin; Drug Therapy, Combination; Humans; Maintenance Chemotherapy; Mesalamine; Randomized Controlled Trials as Topic; Recurrence; Sulfasalazine | 2012 |
Use of Curcumin in Achieving Clinical and Endoscopic Remission in Ulcerative Colitis: A Systematic Review and Meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Curcumin; Endoscopy; Humans; Mesalamine; Remission Induction | 2018 |
Old but Fancy: Curcumin in Ulcerative Colitis-Current Overview.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Curcumin; Humans; Inflammation; Mesalamine | 2022 |
6 trial(s) available for mesalamine and curcumin
| Article | Year |
|---|---|
Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Colonoscopy; Curcumin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mesalamine; Middle Aged; Retrospective Studies; Sulfasalazine; Treatment Outcome | 2006 |
Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Child; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Curcumin; Dietary Supplements; Female; Flatulence; Humans; Inflammatory Bowel Diseases; Male; Medicine, Ayurvedic; Mesalamine; Pilot Projects; Remission Induction; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2013 |
Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study.
Topics: Administration, Rectal; Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Curcumin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enema; Female; Humans; Male; Mesalamine; Middle Aged; Pilot Projects; Remission Induction; Severity of Illness Index; Young Adult | 2014 |
Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Curcumin; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Mesalamine; Middle Aged; Placebos; Treatment Outcome; Young Adult | 2015 |
The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients' self-reported well-being: A randomized double-blind controlled trial.
Topics: Adult; Colitis, Ulcerative; Curcumin; Double-Blind Method; Female; Humans; Male; Mesalamine; Micelles; Middle Aged; Self Report; Treatment Outcome; Young Adult | 2018 |
Novel Bioenhanced Curcumin With Mesalamine for Induction of Clinical and Endoscopic Remission in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-controlled Pilot Study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Curcumin; Double-Blind Method; Humans; Mesalamine; Pilot Projects; Remission Induction; Treatment Outcome | 2021 |
11 other study(ies) available for mesalamine and curcumin
| Article | Year |
|---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
Curcumin for maintenance therapy in ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bias; Colitis, Ulcerative; Curcumin; Humans; Mesalamine; Treatment Outcome | 2007 |
[Curcumin add-on therapy for ulcerative colitis].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Curcumin; Drug Therapy, Combination; Female; Humans; Mesalamine; Treatment Outcome | 2015 |
Spicing up the Treatment of Mild to Moderate Ulcerative Colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Curcumin; Female; Humans; Male; Mesalamine | 2015 |
Curcumin for Inflammatory Bowel Disease: A Caution.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Curcumin; Female; Humans; Male; Mesalamine | 2016 |
What Role Do Immunomodulators Have in Assessing Response to Curcumin as an Add-on Therapy for Patients With Ulcerative Colitis?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Curcumin; Humans; Immunologic Factors; Mesalamine | 2016 |
Reply.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Curcumin; Female; Humans; Male; Mesalamine | 2016 |
Mucoadhesive microparticulates based on polysaccharide for target dual drug delivery of 5-aminosalicylic acid and curcumin to inflamed colon.
Topics: Animals; Chitosan; Colitis; Colon; Curcumin; Drug Carriers; Inflammatory Bowel Diseases; Mesalamine; Polymethacrylic Acids; Rats | 2016 |
Curcumin improves regulatory T cells in gut-associated lymphoid tissue of colitis mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Colon; Curcumin; Cytokines; Dendritic Cells; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Ethanol; Humans; Intestinal Mucosa; Lymphoid Tissue; Male; Mesalamine; Mice; Mice, Inbred C57BL; Random Allocation; Signal Transduction; T-Lymphocytes, Regulatory; Trinitrobenzenesulfonic Acid | 2016 |
Silk Fibroin-Based Fibrous Anal Fistula Plug with Drug Delivery Function.
Topics: Cell Line; Cell Proliferation; Crohn Disease; Curcumin; Drug Delivery Systems; Drug Liberation; Fibroblasts; Fibroins; Humans; Membranes; Mesalamine; Rectal Fistula | 2018 |
Novel Nanostructured Lipid Carriers Co-Loaded with Mesalamine and Curcumin: Formulation, Optimization and In Vitro Evaluation.
Topics: Curcumin; Drug Carriers; Lipids; Mesalamine; Nanostructures; Particle Size; Reproducibility of Results | 2022 |